Search Count: 17
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.33 Å Release Date: 2024-05-01 Classification: VIRAL PROTEIN Ligands: MES, SAM, MGP, EDO, ZN |
 |
Sars-Cov-2 Nsp10-16 Methyltransferase In Complex With Sangivamycin And M7Gpppa-Rna (Cap0-Rna)
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2024-03-20 Classification: VIRAL PROTEIN Ligands: MES, SAM, SGV, EDO, ZN, GTA |
 |
Sars-Cov-2 Nsp10-16 Methyltransferase In Complex With Toyocamycin And M7Gpppa-Rna (Cap0-Rna)
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2024-03-20 Classification: VIRAL PROTEIN Ligands: MES, TO1, MG, ZN, GTA |
 |
Sars-Cov-2 Methyltransferase Nsp10-16 In Complex With Toyocamycin And M7Gpppa (Cap0-Analog)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2024-03-20 Classification: VIRAL PROTEIN Ligands: TO1, GTA, MGP, EDO, ZN |
 |
Sars-Cov-2 Methyltransferase Nsp10-16 In Complex With Sam And M7Gpppa (Cap0-Analog)/M7Gpppam (Cap1-Analog)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2024-03-20 Classification: VIRAL PROTEIN Ligands: GTA, EDO, SAM, MES, EDT, V9G, ZN |
 |
Sars-Cov-2 Nsp10-16 Methyltransferase In Complex With Sangivamycin And M7Gpppa (Cap0-Analog)/M7Gpppam (Cap1-Analog)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.34 Å Release Date: 2024-03-20 Classification: VIRAL PROTEIN Ligands: SGV, GTA, MES, SAH, EDO, V9G, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2023-05-31 Classification: VIRAL PROTEIN Ligands: ATP, EDO, MES, SAM, CL, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2023-05-24 Classification: VIRAL PROTEIN Ligands: EDO, MES, SAM, W08, CL, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2023-05-10 Classification: VIRAL PROTEIN Ligands: EDO, MES, MTA, GLY, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2023-05-10 Classification: VIRAL PROTEIN Ligands: EDO, MES, ADP, SAM, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2023-05-10 Classification: VIRAL PROTEIN Ligands: EDO, MES, SGV, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2023-05-10 Classification: VIRAL PROTEIN Ligands: EDO, MES, 5ID, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2023-05-10 Classification: VIRAL PROTEIN Ligands: EDO, MES, TO1, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-05-03 Classification: VIRAL PROTEIN Ligands: EDO, MES, AMP, ZN, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-03-01 Classification: VIRAL PROTEIN Ligands: EDO, MES, MTA, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-01-18 Classification: VIRAL PROTEIN Ligands: ADN, EDO, MES, CL, ZN |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2022-12-07 Classification: VIRAL PROTEIN Ligands: EDO, MES, TBN, CL, ZN |